Benevolent Platform
by BenevolentAI
AI-enabled drug discovery and development
London, United Kingdom201-500 employeesFounded 2013Updated 12/10/2025
4.2
Based on 0 reviews
About
BenevolentAI operates an AI platform that integrates biomedical data to generate target and drug hypotheses.
User Reviews
Write a ReviewNo reviews yet. Be the first to review this tool!
Write a ReviewIndustries
Pricing
Contact sales
Related Tools
Tempus
VerifiedTempus Labs, Inc.
4.5
0 reviews
AI-enabled precision medicine
HIPAAGDPR
Chicago, IL, USA1000+ employees
PathAI
VerifiedPathAI, Inc.
4.4
0 reviews
AI-powered pathology for drug development
ISO 27001HIPAA
Boston, MA, USA201-500 employees
Unlearn
VerifiedUnlearn.AI, Inc.
4.3
0 reviews
TwinR trials for AI-enhanced clinical studies
ISO 27001
San Francisco, CA, USA51-200 employees